Screen for Modulation of Nucleocapsid Protein Condensation Identifies Small Molecules with Anti-Coronavirus Activity
ACS Chemical Biology · 17.03.2023 · 18 (3) · 583-594
DOI: 10.1021/acschembio.2c00908 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 16.02.2023. Verfasst von Rui Tong Quek und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, United States. Hauptthemen laut MEDLINE: COVID-19, Coronavirus 229E, Human, Coronavirus OC43, Human. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: AbbVie.
Abstract (Originalsprache)
Biomolecular condensates formed by liquid-liquid phase separation have been implicated in multiple diseases. Modulation of condensate dynamics by small molecules has therapeutic potential, but so far, few condensate modulators have been disclosed. The SARS-CoV-2 nucleocapsid (N) protein forms phase-separated condensates that are hypothesized to play critical roles in viral replication, transcription, and packaging, suggesting that N condensation modulators might have anti-coronavirus activity across multiple strains and species. Here, we show that N proteins from all seven human coronaviruses (HCoVs) vary in their tendency to undergo phase separation when expressed in human lung epithelial cells. We developed a cell-based high-content screening platform and identified small molecules that both promote and inhibit condensation of SARS-CoV-2 N. Interestingly, these host-targeted small molecules exhibited condensate-modulatory effects across all HCoV Ns. Some have also been reported to exhibit antiviral activity against SARS-CoV-2, HCoV-OC43, and HCoV-229E viral infections in cell culture. Our work reveals that the assembly dynamics of N condensates can be regulated by small molecules with therapeutic potential. Our approach allows for screening based on viral genome sequences alone and might enable rapid paths to drug discovery with value for confronting future pandemics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Systems Biology, Harvard Medical School, Boston, Massachusetts 02115, United States.
- Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts 02115, United States.
- Drug Discovery Science and Technology, AbbVie Inc., North Chicago, Illinois 60064, United States.
- Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, United States.
ORCID-Profile: Rui Tong Quek, Dan T Nguyen, Pamela A Silver
Förderung
- AbbVie
Zitieren
APA
Quek, R. T., Hardy, K. S., Walker, S. G., Nguyen, D. T., de Almeida Magalhães, T., Salic, A., Gopalakrishnan, S. M., Silver, P. A., & Mitchison, T. J. (2023). Screen for Modulation of Nucleocapsid Protein Condensation Identifies Small Molecules with Anti-Coronavirus Activity. ACS Chemical Biology, 18(3), 583-594. https://doi.org/10.1021/acschembio.2c00908
Vancouver
Quek RT, Hardy KS, Walker SG, Nguyen DT, de Almeida Magalhães T, Salic A, et al. Screen for Modulation of Nucleocapsid Protein Condensation Identifies Small Molecules with Anti-Coronavirus Activity. ACS Chemical Biology. 2023;18(3):583-594. doi:10.1021/acschembio.2c00908
BibTeX
@article{Quek2023,
author = {Quek, Rui Tong and Hardy, Kierra S and Walker, Stephen G and Nguyen, Dan T and de Almeida Magalhães, Taciani and Salic, Adrian and Gopalakrishnan, Sujatha M and Silver, Pamela A and Mitchison, Timothy J},
title = {Screen for Modulation of Nucleocapsid Protein Condensation Identifies Small Molecules with Anti-Coronavirus Activity},
journal = {ACS Chemical Biology},
year = {2023},
volume = {18},
number = {3},
pages = {583--594},
doi = {10.1021/acschembio.2c00908}
}
EUVIMED